Skip to main content
Headlines

In the News

In the News highlights media coverage featuring the Johns Hopkins Bloomberg School of Public Health.

CBS News
|

CDC relaxes its COVID-19 guidelines

The CDC is relaxing some of its COVID-19 guidance now that millions of Americans have greater immunity against the virus due to vaccinations and prior infections.
 

The Washington Post
|

CDC loosens coronavirus guidance, signaling strategic shift

No longer do schools and other institutions need to screen apparently healthy students and employees as a matter of course. The CDC is putting less emphasis on social distancing — and the new guidance has dropped the “six foot” standard.
 

Newsweek
|

Will Monkeypox Put Dent in Thrifting Over Transmission Scares?

The spread prompted many to rush for the vaccine, and others, such as universities, were urged to prepare for potential outbreaks as they brace for the academic year to begin this month. Now, concerns are rising over whether monkeypox could impact thrift stores as more people become scared of transmission.
 

TIME
|

A Hotter World Means More Disease Outbreaks in Our Future

As global temperatures have risen in recent decades, so have the number of outbreaks of infectious diseases. SARS, MERS, Zika, West Nile, COVID-19, and now clusters of monkeypox and polio have all recently threatened public health.
 

The Buffalo News
|

Why improving food access in Buffalo neighborhoods won't be a 'one-size-fits-all solution'

The attack at the Jefferson Avenue Tops left several Buffalo neighborhoods without a convenient source of fresh food. It made the city a national emblem for the plight of urban "food deserts." The term generally describes the nation's thousands of low-income census tracts where an estimated 53.6 million people live outside an easy walk or drive to a full-service supermarket.
 

Associated Press
|

U.S. will stretch monkeypox vaccine supply with smaller doses

U.S. health officials on Tuesday authorized a plan to stretch the nation’s limited supply of monkeypox vaccine by giving people just one-fifth the usual dose, citing research suggesting that the reduced amount is about as effective.